Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Watching Shares Of GSK; UBS Note Says ACIP Working Group Recommends Universal RSV Vaccine for Age 75+ From SCD; No Endorsement for Ages 50-59 Due to Limited Data; 60-74 Recommendation Only for "At Risk"

Author: Benzinga Newsdesk | June 26, 2024 01:38pm

Posted In: GSK UBS